eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. Harnessing the latest gene-editing techniques, eGenesis’ mission is to solve the global organ shortage crisis by developing a scalable alternative to allotransplantation. eGenesis is reinvigorating the field of xenotransplantation by addressing the key virology and immunology hurdles that have prevented its advancement to date, and is developing commercially-viable products to save and improve the lives of patients who are waiting for an organ transplant.
Looking for a particular eGenesis, Inc. employee's phone or email?
eGenesis, Inc. Questions
The eGenesis, Inc. annual revenue was $20.5 million in 2026.
Michael Curtis is the President and CEO of eGenesis, Inc..
114 people are employed at eGenesis, Inc..
eGenesis, Inc. is based in Cambridge, Massachusetts.
The NAICS codes for eGenesis, Inc. are [5417, 54, 541].
The SIC codes for eGenesis, Inc. are [87, 873].
Top eGenesis, Inc. Employees
-
Michael Curtis
President and CEO at eGenesis, Inc.
Waltham, MA, US25 -
Elizabeth Roberts
Chief People Officer at eGenesis, Inc.
Cambridge, MA, US35+ -
Jennifer Bergheiser
Chief Business Officer at eGenesis, Inc.
Cambridge, MA, US25+ -
25+
-
Ben Beckman
VP of Finance at eGenesis, Inc.
Cambridge, MA, US13 -
Wenning Qin
SVP, Research at eGenesis, Inc.
Cambridge, MA, US23 -
43
-
Lauren Tahmoush
Vice President, Finance at eGenesis, Inc.
Boston, MA, US12
Related Companies
